A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company's success next year.
from MobiHealthNews https://ift.tt/1zbkRq6
https://ift.tt/ASOQthH
from MobiHealthNews https://ift.tt/1zbkRq6
https://ift.tt/ASOQthH